Substance Abuse Treatment Market: Drivers, Restraints, Opportunities, and Threats (2020-2027)

 Market Scenario

Global substance abuse treatment market size is expected to grow significantly over the forecast period. It is projected to grow at a CAGR of 11.6% over the forecast period. 

Substance abuse refers to the harmful use of psychoactive substances, including alcohol and illicit drugs.

Increasing trends of cigarette smoking in teenagers is one of the prominent factors driving the Substance Abuse Treatment market. According to the 2015 study published in the Clinical and Translational Investigation journal, More than 60% of individuals start smoking at the age of 13 and more than 90% individuals start smoking before reaching 20 years. It is also reported that 5.8% of the Mexican population comprises adolescents between 13 and 15 years. Of them, 42.8% tried a cigarette at some point in their life.

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/7230

Various other factors such as increasing incidence of drug addiction, technological advancement in the diagnostics industry, rising patient awareness about substance abuse treatment and improvement in treatment rates and healthcare infrastructure are also expected to propel the growth of the market.

However, poor treatment compliance in some countries and reluctance of individuals for accessing treatment can hamper the market growth over the forecast period.

Segmentation

The global substance abuse treatment market is segmented based on abuse type, treatment type, end user, and region.

The global market for substance abuse treatment, by abuse type is segmented into alcohol dependence, tobacco/nicotine addiction, and drug abuse. The drug abuse segment is anticipated to hold the largest market share owing to the increasing addiction of opioid.

The market, by treatment type, is segmented into alcohol addiction treatment, tobacco/nicotine addiction treatment, and drug abuse treatment. The alcohol addiction treatment segment is further classified as disulfiram, acamprosate, and naltrexone. The tobacco/nicotine addiction treatment segment is further classified as nicotine replacement treatment, and non-nicotine medication. The nicotine replacement treatment segment includes nicotine patch, nicotine gum, nicotine lozenge, nicotine spray, and nicotine inhaler. The non-nicotine medication segment includes bupropion, and varenicline. The drug abuse treatment segment is further classified as methadone, buprenorphine, and naltrexone.

Based on end user, the market is segmented into outpatient treatment centres, residential treatment centres, and inpatient treatment centres.

In the current scope of the study, the above-mentioned segments are covered into the four global regions, namely the Americas, Europe, Asia-Pacific and the Middle East & African region.

The substance abuse treatment market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.

The European substance abuse treatment market has been segmented into Western Europe and Eastern Europe. Western Europe has been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.  The substance abuse treatment market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The substance abuse treatment market in the Middle East & Africa has been segmented into the Middle East and Africa.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/substance-abuse-treatment-market-7230

 

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Transdermal (Percutaneous) Drug Delivery Systems Market 2020 Analysis, Industry Size, Share Leaders, Current Status by Major vendors and Trends by Forecast to 2027

 The global transdermal (percutaneous) drug delivery systems market size is expected to register a healthy CAGR over the forecast period. The market held a market value of USD 5,400.2 million in 2017 and is projected to grow at a CAGR of 4.6% during the forecast period from 2018 to 2023. Transdermal drug delivery system (TDDS) delivers drugs through the skin to systemic circulation at a predetermined rate and maintain the effective concentrations clinically over an extended period. TDDS also called as patches are dosage forms that deliver a therapeutically effective amount of drug via the patients’ skin. Worldwide growing geriatric population along with rising in the prevalence of chronic diseases is the leading factor driving the market growth. In addition, rapid technological advancements in transdermal drug delivery systems and increasing adoption of third-generation delivery systems are expected to augment the market growth during the forecast period. The geriatric population is more prone to develop Q fever. The elderly population across the world is on the surge. The World Health Organization (WHO) reported that the worldwide population aged 60 years and above was 962.0 million in 2017, which is projected to increase to over 2.0 billion by 2050 and further would reach to 3.1 billion by 2100.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/7545

However, disadvantages of delivery systems including edema and irritation, natural limits of drug entry imposed by the skin’s impermeability, and lack of adhesion of the transdermal system to different skin types are anticipated to hinder the market growth over the forecast period. Additionally, drugs that require high blood levels cannot be administered through TDDS as it is limited only to potent molecules, those requiring a daily dose of 10 mg or less, thereby affecting the market growth.

Transdermal Drug Delivery Systems Market Segmentation

 

The global transdermal (percutaneous) drug delivery systems market has been segmented into product, technology, application, and region.

By product, the market has been segmented into transdermal patches and transdermal semisolids. The transdermal patches segment is further categorized into drug-in-adhesive patches, matrix patches, reservoir membrane patches, and microneedle patches. The transdermal semisolids segment is additionally divided into gels, ointments, and sprays. The transdermal patches segment spearheaded the market in 2017 due to its benefits offered such as improved bioavailability, reduced dosing frequency, lower adverse events, enhanced patient compliance (non-invasive nature), painless application, and drug input termination at any point by the removal of the patch.

On the basis of technology, the market has been divided into electric current, iontophoresis, electroporation, ultrasound, microporation, thermal, and others.

Based on application, the market has been categorized into pain management, cardiovascular diseases, hormone replacement therapy, central nervous system disorders, smoking cessation, contraception, and others.

The global transdermal (percutaneous) drug delivery systems market has been segmented by region into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The transdermal (percutaneous) drug delivery systems market in the Americas has further been segmented into North America and Latin America, with the North American market divided into the US and Canada.

The European transdermal (percutaneous) drug delivery systems market has been segmented into Western Europe and Eastern Europe. The Western Europe transdermal (percutaneous) drug delivery systems market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.

The transdermal (percutaneous) drug delivery systems market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The transdermal (percutaneous) drug delivery systems market in the Middle East & Africa has been segmented into the Middle East and Africa.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/transdermal-drug-delivery-systems-market-7545

Dental Lasers Market – Qualitative Insights by 2027

Market Scenario  

The global Dental Lasers Market size is estimated reach USD 2.3 billion by 2023 with a CAGR of 5.2% during the forecast period (2017-2023).

The term “LASER” stands for ‘Light Amplification by the Stimulated Emission of Radiation’. Lasers emit a thin and concentrated beam of light, producing a thermal output. This thermal output has been used in the dentistry for endodontic treatment, oral surgery, implantology, peri-implantitis, periodontics, and others.

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/7375

From the past few years, the dental laser market has expanded with a steady CAGR. Factors such as, increasing prevalence of dental diseases, rising dental healthcare expenditure, growing R&D by the major market players, and increasing dental tourism are estimated to drive the market during the forecast period. Dental caries is a common chronic tooth tissue disease and effects ~90% of the world population (once in the lifetime). In the presence of such high prevalence of dental caries, demand of related therapeutics has increased. It is reportable that dental caries can be removed effectively by the application of dental lasers. Fast procedure and minimal invasion are some of the advantages associated with caries removal by dental lasers.

However, factors such as high cost of dental laser, changing reimbursement policies, lack of skilled work-force and awareness in the developing economies restraints the market growth.  A sophisticated laser system is estimated to cost about USD 300, 000 to USD 500,000 or more.

Segmentation

The global dental lasers market is segmented based on product, application, and end users.

The dental lasers market, by product is segmented into soft tissue dental lasers and all tissue dental lasers. The soft tissue dental lasers is sub-segmented into diode lasers systems, CO2 laser systems, and Nd:YAG laser systems. The all tissue dental lasers segment is divided into Er:YAG laser systems, and Er,Cr:YSGG laser systems.

By application, the market is segmented into endodontic treatment, oral surgery, implantology, peri-implantitis, periodontics, and others.

The dental lasers market, by end user is segmented into hospitals & clinics, ambulatory surgical units, academic & research organizations.

Based on region, the global dental lasers market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The Americas is sub-segmented into North America and Latin America. The North American region is further segmented into the US and Canada. The European region is divided into two, namely, Western Europe and Eastern Europe. Western Europe is further classified into Germany, Italy, France, the UK, Spain, and the rest of Western Europe. The Asia-Pacific region is sub-segmented into Japan, China, India, Australia, the Republic of Korea, and the rest of Asia-Pacific. The Middle Eastern and African region is sub-segmented into the United Arab Emirates, Saudi Arabia, Oman, Kuwait, Qatar, and the rest of the Middle East and Africa.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/dental-lasers-market-7375

 

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Clinical Laboratory Services Market Trends Analysis Research Report 2020-2027

 Market Snapshot:

MRFR reports that the clinical laboratory services market size is likely to exhibit a sound growth rate during the forecast period (2018-2023). The global clinical laboratory services market is expected to surpass a valuation of USD 274,400 Million by 2023. Demand for clinical laboratory services is on the rise due to the increased healthcare expenditure coupled with growing awareness about such services. North America is a major region for these services and presents lucrative growth opportunities to market players. Moreover, existence of advanced healthcare infrastructure and widespread availability of lab experts and technicians is supplementing the growth of the clinical laboratory services market in North America. Meanwhile, APAC is also likely to remain under the investment radar of companies operating on a global level.

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/7145

Synopsis:

MRFR in its latest report offers a detailed observation on the global clinical laboratory services market. It also includes a revenue analysis and market projection until 2023. All the important parameters are considered for analysis. In this report, the market element such impacting trends, drivers, opportunities and threats are thoroughly discussed. The scope of the discussion covers different types of clinical laboratory services such as biochemistry, microbiology, endocrinology, hematology, histopathology, cytology and genetic testing. Application areas considered for laboratory services are independent, laboratory, reference Laboratory and hospital laboratory.

Report Coverage:

Historical clinical laboratory services market trends, forecast, dynamics, value by region as well as by segmentation, country-level analysis for each segment, key player’s market share analysis and factor analysis which covers supply chain and Porter’s five forces analysis of the market.

Companies Covered:

Laboratory Corporation of America Holdings, Mayo Medical Laboratories, Spectra Laboratories Inc, Unilabs, Bio-Reference Laboratories, Clinical Reference Laboratory, Adicon Clinical Laboratory, Amedes Holdings, Lifelabs Medicals Laboratories, Quest Diagnostics Incorporated, Synlab International, ACM Medical Laboratory, Eurofins Scientific, Cerba Healthcare and Sonic Healthcare.

Research Methodology:

MRFR leverages its optimum statistical solution for assessment of critical elements to ensure the deliverance of in-depth clinical laboratory services market foresight. The multi-layered research module is utilized for qualitative and quantitative analysis of governing factors and macroeconomic indicators of the market such as current market dynamics, historical trends, consumer landscape, growth opportunities, and challenges. Primary and secondary research processes form the foundation of the research methodology utilized for prudent clinical laboratory services market analysis. The collected data is verified through inputs from surveys, personal interviews, research publications, paid databases, and other credible sources available in public domain. In addition, the top-down and bottom-up approaches are employed for authentication of research findings which are then verified using a strong data triangulation technique.

Global Clinical Laboratory Services Market – Segmental Analysis:

This MRFR report offers a detailed segmental analysis of the global clinical laboratory services market based on type and application. By type, the market is segmented into biochemistry, endocrinology, microbiology, hematology, histopathology, cytology, genetic testing, and others. Among these, the hematology segment held 25.6% market share in 2017. It is estimated to retain its dominant position through the forecast period. The growth of the segment can be ascribed to the large-scale prevalence of blood cancer. As per the 2018 statistics revealed by the Leukemia & Lymphoma Society, around 60,300 people are projected to be diagnosed with leukemia, whereas, 24,370 people are expected to succumb to the disease.

By application, the global clinical laboratory services market has been segmented into independent laboratory, reference laboratory, and hospital laboratory. Among these, the hospital laboratory segment is likely to dominate the global market over the assessment period. The valuation of the segment has been predicted to grow from USD 152,574 Mn in 2017 to USD 185,982 Mn by 2023-end. Factors such as the availability of different tests and favorable reimbursement policies for tests in the region are presumed to drive the growth of the clinical laboratory services market in the foreseeable future.

Regional Outlook:

By region, the global clinical laboratory services market has been segmented into Americas, Europe, Asia Pacific, and the Middle East & Africa. Americas accounted for the maximum share of the market in 2017 and is forecasted to grow significantly over the next couple of years. The factors that are poised to aid the proliferation of the clinical laboratory services market in the region include favorable reimbursement policies, growth of clinical laboratories, and increasing count of lab technicians. It has been estimated that the valuation of the market will touch USD 108,913 Mn by the end of 2023.

Europe is an important growth pocket forecasted to hold the second spot in the global marketplace. The competitive landscape of the market is growth inducive owing to the presence of major prominent key players, rising healthcare expenditure, rising count of clinical tests, etc. The Middle East & Africa is expected to reach a valuation of USD 14,067 Mn by 2023-end from USD 11,252 Mn in 2017.

Asia Pacific is expected to emerge as the fastest growing regional market over the projection period. The region signifies strong growth opportunities for the expansion of the market. It is estimated to thrive at a CAGR of 5% during the forecast period. The rising burden of diseases such as cancer, diabetes, etc. is the driving force of market growth in the region.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/clinical-laboratory-services-market-7145

Surgical Microscopes Market to Witness Widespread Expansion During 2020-2027

 Market Scenario

The global surgical microscopes market size is expected to grow significantly over the forecast period. The market held a market value of USD 574.34 million in 2017 and is projected to grow at a CAGR of 11.63% over the forecast period.

Surgical microscopes are the optical microscopes specially designed for the use in surgical settings. These surgical microscopes have a high magnification resolution which is highly beneficial during the microsurgeries. Also, surgical microscopes can be customized which is helpful for the component sterilization, and disinfection to ensure the complete cross-infection control. Generally, even the basic surgical microscopes can cost up to several thousand dollars. The advanced versions of such microscopes have high price points. There are several factors that fuel the growth of the global surgical microscopes market. These include, increasing number of surgical procedures, high demand for the minimally invasive surgeries, and continuous development in the medical sector to come up with better surgical approaches. Moreover, development of customized microscopy solutions, and increasing use of fluorescence image-guided surgery (FIGS) is expected to boost the growth of the market during the forecast period.

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/7065

On the other hand, there are several factors such as high cost of the microscopic devices, stringent regulatory norms, and lack of required medical infrastructure in the developing and underdeveloped regions which are likely to thwart the growth of the surgical microscopes market to an extent.

Segmentation

The global surgical microscopes market has been segmented into type, application and end user.

Based on types, the market has been segmented into, On casters microscopes, wall mounted microscopes, table top microscopes, and ceiling mounted microscopes. The on casters microscopes segment is expected to account for the largest share in the global surgical microscopes market in 2017. This large share is majorly attributed to its convenience in the use as compared to other products.

Based on application, the market has been segmented into neurosurgery & spine surgery, ophthalmology, ENT surgery, dentistry, oncology, plastic & reconstructive surgery, urology, gynecology, and other. The neurosurgery & spine surgery segment is expected to account for the largest share in the global surgical microscopes market in 2017 followed by ophthalmology segment.

Based on end users, the market has been segmented into hospitals, physician’s clinic, academic and research institutes, and other outpatient settings. The hospitals segment is expected to account for the largest share in the global surgical microscopes market in 2017. At the same time, the high awareness about the aesthetics, dental hygiene and increasing rate of ophthalmic surgical cases in the developed and developing countries has led physician’s clinic segment to grow at the fastest rate during the forecast period.

Based on the regions, the market for surgical microscopes is segmented in to, the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The surgical microscopes market in the Americas region has further been segmented into North America and South America, where-in the North American market is further divided into the US and Canada.

European surgical microscopes market has been segmented into Western Europe and Eastern Europe where-in Western Europe region is further divided into Germany, France, the UK, Italy, Spain, and the rest of Western Europe. 

The surgical microscopes market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The surgical microscopes market in the Middle East & Africa has been segmented into regions such as the Middle East & Africa.

Key players

Accu-Scope Inc., Alltion (Wuzhou) Co., Ltd., Arri Medical (Arri Group), Carl Zeiss AG, Danaher Corporation, Haag-Streit Surgical GmbH, Leica Microsystems GmbH, Novartis AG, Olympus Corporation, Seiler Precision Microscopes, Takagi Seiko Co. Ltd., and Topcon Medical Systems, Inc. are some of the key players in the global surgical microscopes market.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/surgical-microscopes-market-7065

 

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Cell Culture Media Market: Drivers, Restraints, Opportunities, and Threats (2020-2027)

 The Global Cell Culture Media Market is expected to register a CAGR of 6.9% and is projected to reach USD 2,070.71 million by 2023. A cell culture media is a growth media designed to support the growth of cells. A cell culture media is composed of the appropriate composition of amino acids, vitamins, inorganic salts, glucose, serum, etc. It may require additional supplementary reagents and sera such as growth factors, hormones, lipids, trace elements, and minerals which are necessary for cell cultures to grow and survive in their incubation environment.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/4462

The cell culture media market is driven by the growing pharmaceutical industry, rising biopharmaceutical drugs in the pipeline, increasing prevalence of cancer and infectious diseases, and increasing geriatric population. However, the cost of cell culture media and contamination of media are a threat to the growth of the market.

Market Dynamics

Rising research and development in the pharmaceutical and biotechnology industry is driving the growth of the cell culture media market. For instance, according to a recent survey, the pharmaceutical and biotechnology industry in the US spent a total of USD 102 billion on research and development in 2015. Additionally, according to the National Institute for Health Research, the Association of the British Pharmaceutical Industry (ABPI) invested over Euro 4.1 billion in 2015 just in the UK on R&D, looking for breakthroughs for conditions such as cancer, dementia, and rare genetic diseases. This growing research and development in the field of healthcare are leading to an upward demand for cell culture media.

Segmentation

The global cell culture media market has been segmented into product type, application, and end user. By product type, the market has been segregated into reagents, media, and sera. Based on media, the market has been divided into classical media, stem cell media, serum-free media, and others. The market, based on stem cell media, is further categorized as bone marrow, neural stem cells (NSCs), mesenchymal stem cells (MSCs), and embryonic stem cells (ESCs).

Based on application, the market has been bifurcated into biopharmaceutical, tissue-culture and manufacturing, gene therapy, cytogenetic, and others. By end user, the market has been classified as biopharmaceutical companies, academic and research laboratories, hospitals and diagnostics centers, and others.

Key Players

The major players in the global cell culture media market are Merck KGaA (Germany), Bio-Rad Laboratories, Inc. (US), Thermo Fisher Scientific Inc. (US), Lonza (Switzerland), GE Healthcare (US), Becton, Dickinson and Company (US), HiMedia Laboratories (India), Corning Incorporated (US), PromoCell (Germany), Sera Scandia A/S (Denmark), The Sartorius Group (Germany), and Fujifilm Holdings Corporation (Japan).

Some of the key strategies followed by the players operating in the global cell culture media market were mergers, acquisitions, and new product launches.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/cell-culture-media-market-4462

 

About Us:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Blockchain in Pharmaceutical Supply Chain Management Market – Insights on Upcoming Trends 2027

 Market Scenario

The Global Blockchain in Pharmaceutical Supply Chain Management Market is expected to register a CAGR of 22.5% during the forecast period of 2019 to 2024.

A blockchain solution can make a substantive difference to the pharmaceutical supply chain. At every stage of the supply chain process, barcodes would be scanned and recorded onto a blockchain ledger system which, in sequence, records and creates an audit trail of the drug journey. Sensors can also be combined into the supply chain, with temperature or humidity being noted onto the ledger system. This is most important for drugs requiring fridge storage, such as insulin or expensive, specially manufactured medicines.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/8009

Furthermore, through the use of blockchain, the supply chain process of the drugs can become more secure and streamlined. Every delivery can be tracked, with the delivery driver traced through biometric measures. Every checkpoint concerning the drugs supply is recorded and traced via biometric measures, 2d barcode scans, or sensor technology. As the drug is tracked from its manufacturing unit to the patient, the whole of the drug supply chain becomes seamless, precise, audited, and safe.

Segmentation

The global blockchain in pharmaceutical supply chain management is segmented on the basis of application, end user, and region.

On the basis of application, the global blockchain in pharmaceutical supply chain management market is segmented into product traceability, risk and compliance management, payment & settlement, others. The market by end user is segmented into manufacturers, distributors, healthcare providers

Key Players

Some of the key players in the Global Blockchain In Pharmaceutical Supply Chain Management Market are IBM, Microsoft, SAP SE, Oracle, Tibco Software, Auxesis Group, Omnichain, Vechain Foundation, Chainvine, Applied Blockchain, AWS, Huawei, Guardtime, BTL Group, Bitfury, Digital Treasury Corporation, Blockverify, Nodalblock, Peer Ledger, and others.

Regional Market Summary

The global blockchain in pharmaceutical supply chain management market is segmented on the basis of regions: Americas, Europe, Asia-Pacific, and the Middle East & Asia. The Americas account for the major share of the market owing to the well-developed technology, high healthcare expenditure, and the presence of the major pharmaceutical players. Europe accounted for the second largest market, which is followed by Asia-Pacific. Well-developed healthcare infrastructure and higher healthcare funds have driven the European blockchain in pharmaceutical supply chain management market. Asia-Pacific is the fastest growing blockchain in pharmaceutical supply chain management market. Rapidly changing healthcare sector, and the presence of huge opportunities for the development of this market have paved the way for market growth. However, the Middle East and Africa holds the least share in the global blockchain in pharmaceutical supply chain management market. The presence of poor economies and low per capita income, especially within Africa, restrains the growth within the region. A majority of the market share within this region is estimated to be held by the Middle East due to increasing government funding in the healthcare for healthcare, and presence of developed economies like UAE, Kuwait, Dubai, and others.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/blockchain-pharmaceutical-supply-chain-management-market-8009

 

About Us:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com